Deroy & Devereaux Private Investment Counsel’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-182,328
| Closed | -$15.9M | – | 175 |
|
|
2024
Q1 | $15.9M | Sell |
182,328
-2,520
| -1% | -$215K | 0.97% | 52 |
|
|
2023
Q4 | $15.2M | Sell |
184,848
-4,164
| -2% | -$317K | 1.01% | 50 |
|
|
2023
Q3 | $14.8M | Sell |
189,012
-2,404
| -1% | -$201K | 1.08% | 43 |
|
|
2023
Q2 | $16.9M | Buy |
191,416
+1,085
| +0.6% | +$93.4K | 1.17% | 44 |
|
|
2023
Q1 | $15.3M | Sell |
190,331
-1,647
| -0.9% | -$134K | 1.17% | 42 |
|
|
2022
Q4 | $14.9M | Buy |
191,978
+2,422
| +1% | +$196K | 1.15% | 45 |
|
|
2022
Q3 | $15.3M | Buy |
189,556
+530
| +0.3% | +$47.6K | 1.33% | 39 |
|
|
2022
Q2 | $17M | Buy |
189,026
+4,966
| +3% | +$503K | 1.4% | 36 |
|
|
2022
Q1 | $20.4M | Buy |
184,060
+1,978
| +1% | +$209K | 1.48% | 29 |
|
|
2021
Q4 | $18.8M | Buy |
182,082
+51,518
| +39% | +$5.97M | 1.39% | 40 |
|
|
2021
Q3 | $16.4M | Sell |
130,564
-1,653
| -1% | -$214K | 1.28% | 45 |
|
|
2021
Q2 | $16.4M | Sell |
132,217
-511
| -0.4% | -$64.2K | 1.23% | 46 |
|
|
2021
Q1 | $15.7M | Sell |
132,728
-1,180
| -0.9% | -$138K | 1.24% | 44 |
|
|
2020
Q4 | $15.7M | Sell |
133,908
-10,430
| -7% | -$1.15M | 1.39% | 38 |
|
|
2020
Q3 | $15M | Sell |
144,338
-493
| -0.3% | -$49.5K | 1.57% | 33 |
|
|
2020
Q2 | $13.3M | Sell |
144,831
-2,250
| -2% | -$216K | 1.47% | 34 |
|
|
2020
Q1 | $13.3M | Sell |
147,081
-1,361
| -0.9% | -$145K | 1.73% | 30 |
|
|
2019
Q4 | $16.8M | Buy |
148,442
+2,551
| +2% | +$280K | 1.47% | 37 |
|
|
2019
Q3 | $15.8M | Sell |
145,891
-2,681
| -2% | -$280K | 1.54% | 36 |
|
|
2019
Q2 | $14.5M | Sell |
148,572
-2,598
| -2% | -$237K | 1.39% | 39 |
|
|
2019
Q1 | $13.8M | Buy |
151,170
+838
| +0.6% | +$75K | 1.38% | 38 |
|
|
2018
Q4 | $13.7M | Buy |
150,332
+705
| +0.5% | +$65.9K | 1.58% | 33 |
|
|
2018
Q3 | $14.7M | Sell |
149,627
-14
| -0% | -$1.29K | 1.47% | 37 |
|
|
2018
Q2 | $12.8M | Buy |
149,641
+899
| +0.6% | +$75.1K | 1.31% | 40 |
|
|
2018
Q1 | $11.9M | Buy |
148,742
+404
| +0.3% | +$33.3K | 1.27% | 44 |
|
|
2017
Q4 | $12M | Buy |
148,338
+1,965
| +1% | +$157K | 1.26% | 44 |
|
|
2017
Q3 | $11.4M | Buy |
146,373
+566
| +0.4% | +$47K | 1.28% | 44 |
|
|
2017
Q2 | $12.9M | Buy |
145,807
+434
| +0.3% | +$36.6K | 1.48% | 37 |
|
|
2017
Q1 | $11.7M | Sell |
145,373
-3,849
| -3% | -$301K | 1.36% | 39 |
|
|
2016
Q4 | $10.6M | Sell |
149,222
-626
| -0.4% | -$49.2K | 1.26% | 42 |
|
|
2016
Q3 | $12.9M | Buy |
149,848
+1,700
| +1% | +$148K | 1.63% | 31 |
|
|
2016
Q2 | $12.9M | Sell |
148,148
-74,353
| -33% | -$6.01M | 1.71% | 25 |
|
|
2016
Q1 | $16.7M | Sell |
222,501
-4,211
| -2% | -$317K | 2.28% | 3 |
|
|
2015
Q4 | $17.4M | Sell |
226,712
-4,028
| -2% | -$303K | 2.4% | 3 |
|
|
2015
Q3 | $15.4M | Sell |
230,740
-2,079
| -0.9% | -$153K | 2.21% | 6 |
|
|
2015
Q2 | $17.3M | Sell |
232,819
-15,752
| -6% | -$1.2M | 2.23% | 6 |
|
|
2015
Q1 | $19.4M | Buy |
248,571
+100,076
| +67% | +$7.59M | 2.39% | 6 |
|
|
2014
Q4 | $10.7M | Buy |
148,495
+595
| +0.4% | +$41.3K | 1.38% | 34 |
|
|
2014
Q3 | $9.16M | Sell |
147,900
-406
| -0.3% | -$25.8K | 1.38% | 37 |
|
|
2014
Q2 | $9.46M | Sell |
148,306
-2,470
| -2% | -$150K | 1.38% | 36 |
|
|
2014
Q1 | $9.28M | Buy |
150,776
+1,868
| +1% | +$109K | 1.41% | 35 |
|
|
2013
Q4 | $8.55M | Buy |
148,908
+2,487
| +2% | +$141K | 1.33% | 37 |
|
|
2013
Q3 | $7.8M | Sell |
146,421
-2,668
| -2% | -$144K | 1.45% | 36 |
|
|
2013
Q2 | $7.67M | Buy |
+149,089
| New | +$7.37M | 1.46% | 33 |
|
Other funds holding MDT
Deroy & Devereaux Private Investment Counsel's MDT Position: Q2 2024 in Review
Deroy & Devereaux Private Investment Counsel sold out of Medtronic (MDT) in Q2 2024, closing a stake of 182,328 shares — an estimated $15.9M sold.
Deroy & Devereaux Private Investment Counsel first reported a position in MDT in Q2 2013 and held it in 44 quarters. The position peaked at $20.4M in Q1 2022. 2,027 funds tracked by Wall St. Rank hold MDT as of Q2 2024.
- Deroy & Devereaux Private Investment Counsel reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
- Deroy & Devereaux Private Investment Counsel sold 182,328 Medtronic shares in Q2 2024, an estimated $15.9M.
- Deroy & Devereaux Private Investment Counsel first reported a position in Medtronic in Q2 2013 and held it in 44 quarters.
- Deroy & Devereaux Private Investment Counsel's Medtronic position peaked at $20.4M in Q1 2022.
- 2,027 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.
Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q2 2024, filed 29 Jul 2024.